Contact details
For medical information
Tel: +371 80 205 045
Email: QUZ52333@gsk.com
To report an adverse event
Tel: +371 80 205 045
Email: QUZ52333@gsk.com
Our Privacy Notice outlines how GSK handles the processing of personal information when dealing with your enquiry, complaint or adverse event report.
For questions on our Ellipta and Nucala portfolio
Please contact Berlin-Chemie Menarini
Tel: +371 67 103 210
For questions on supply and distribution of all other GSK medicines and vaccines
Please contact Tamro
Tel: +371 67 067 842
For government and media enquiries
For any other enquires
EFPIA disclosure
GSK fully supports the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on the disclosure of individual transfer of value from pharmaceutical companies to healthcare professionals and healthcare organisations
We believe that it helps to create a better understanding about how the pharmaceutical industry partners and collaborates with HCPs and HCOs, and so increase confidence in the way that industry and the healthcare professions work together.
We publish disclosure reports in line with the EFPIA Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations.